Effects on Cell Viability 641the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett
463:235–240
Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V (2000)
Suppression of nerve growth factor trk receptors and prolactin receptors by endo-
cannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Endocrinology 141:118–126
Mimeault M, Pommery N, Wattez N, Bailly C, Henichart JP (2003) Anti-proliferative and
apoptotic effects of anandamide in human prostatic cancer cell lines: implication of
epidermal growth factor receptor down-regulation and ceramide production. Prostate
56:1–12
Molina-Holgado E, Vela JM, Arévalo-Martín A, Almazán G, Molina-Holgado F, Borrell J,
Guaza C (2002) Cannabinoids promote oligodendrocyte progenitor survival: involve-
ment of cannabinoid receptors and phosphatidylinositol 3-kinase/Akt signaling. J Neu-
rosci 22:9742–9753
Muller-Vahl KR(2003) Cannabinoidsreduce symptomsof Tourette’ssyndrome. ExpertOpin
Pharmacother 4:1717–1725
Munro S, Thomas KL, Abu Shaar M (1993) Molecular characterization of a peripheral
receptor for cannabinoids. Nature 365:61–65
Munson AE, Harris LS, Friedman MA, Dewey WL, Carchman RA (1975) Antineoplastic
activity of cannabinoids. J Natl Cancer Inst 55:597–602
Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA (1999) Cannabi-
noids and neuroprotection in global and focal cerebral ischemia and in neuronal cul-
tures. J Neurosci 19:2987–2995
Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E
(2001) An endogenous cannabinoid (2AG) is neuroprotective after brain injury. Nature
413:527–531
Parmentier-Batteur S, Jim K, Mao O, Xie L, Greenberg DA (2002) Increased severity of stroke
in CB1 cannabinoid receptor knock-out mice. J Neurosci 22:9771–9775
Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci
4:873–884
Portella G, Laezza C, Laccetti P, De Petrocellis L, Di Marzo V, Bifulco M (2003) Inhibitory
effectsofcannabinoidCB1receptorstimulationontumorgrowthandmetastaticspread-
ing: actions on signals involved in angiogenesis and metastasis. FASEB J 17:1771–1773
Riboni L, Campanella R, Bassi R, Villani R, Gaini SM, Martinelli-Boneschi F, Viani P,
TettamantiG(2002)Ceramidelevelsareinverselyassociatedwithmalignantprogression
of human glial tumors. Glia 39:105–113
Roth MD, Baldwin GC, Tashkin DP (2002) Effects of delta-9-tetrahydrocannabinol on human
immune function and host defense. Chem Phys Lipids 31:229–239
Rueda D, Galve-Roperh I, Haro A, Guzmán M (2000) The CB1 cannabinoid receptor is
coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol 58:814–820
Rueda D, Navarro B, Martínez-Serrano A, Guzmán M, Galve-Roperh I (2002) The en-
docannabinoid anandamide inhibits neuronal progenitor cell differentiation through
attenuation of the Rap1/B-Raf/ERK pathway. J Biol Chem 277:46645–46650
Samson MT, Small-Howard A, Shimoda LM, Koblan-Huberson M, Stokes AJ, Turner H
(2003) Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol
170:4953–4962
Sánchez C, Galve-Roperh I, Canova C, Brachet P, Guzmán M (1998a)∆9-TetraHydro-
Cannabinol induces apoptosis in C6 glioma cells. FEBS Lett 436:6–10
Sánchez C, Galve-Roperh I, Rueda D, Guzmán M (1998b) Involvement of sphingomyelin
hydrolysis and the mitogen-activated protein kinase cascade in the∆9-tetrahydro-
cannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol
Pharmacol 54:834–843
Sánchez C, de Ceballos ML, Gómez del Pulgar T, Rueda D, Corbacho C, Velasco G, Galve-
Roperh I, Huffman JW, Ramón y Cajal S, Guzmán M (2001a) Inhibition of glioma growth
in vivo by selective activation of the CB2 cannabinoid receptor. Cancer Res 61:5784–5789